Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alarum To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Alarum between March 20, 2025 and July 2, 2026 and would like to discuss...
LOS ANGELES, Sept. 28, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to DICK's Sporting Goods, Inc. (DKS) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN DICK'S SPORTING...
New York, New York--(Newsfile Corp. - September 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation ("UWM Holdings" or the "Company") (NYSE: UWMC) on behalf of investors that purchased or otherwise acquired UWM Holdings securities between March 9, 2026 and August 5, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in UWM Holdings and have suffered losses, you may CLICK HERE to contact us. You may...
CHICAGO, September 28, 2026--Meitheal Pharmaceuticals, Inc. ("Meitheal"), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic injectables, fertility, biologic, and branded products, today announced that the U.S. Food and Drug Administration ("FDA") has approved a high-concentration formulation ("HCF") for YUSIMRY® (adalimumab-aqvh), as an interchangeable biosimilar to Humira®.
New marketplace integration drops payment infrastructure directly into the Webflow canvas, ending external domain redirects, maximizing merchant conversions, and unlocking new possibilities for organizations leveraging Webflow. TROY, Mich., Sept. 28, 2026 /PRNewswire/ -- North, a...
MINNEAPOLIS, September 28, 2026--Pivot Bio, one of the world's leading agtech companies, announced today that it has significantly expanded production and availability of Pivot Bio RETURN® for winter wheat this fall in response to strong farmer demand, bringing the product to more growers and more acres across U.S. wheat country.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pentair To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Pentair between March 11, 2025 and July 14, 2026 and would like to discuss...
KANSAS CITY, Kan. (Sept. 28, 2026) – Camry driver Thomas Annunziata captured his first career ARCA Menards Series title last Friday with a fifth-place finish at Kansas Speedway. This championship is the first in ARCA competition for Nitro Motorsports. The […] The post Toyota Driver Thomas Annunziata Wins First ARCA Championship appeared first on Toyota USA Newsroom.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UWM To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in UWM between March 9, 2026 and August 5, 2026 and would like to discuss your...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 28, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ:UNCY) securities. If you suffered a loss on your Unicycive Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Unicycive Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 28, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Honeywell Aerospace Inc. (NASDAQ:HONA) securities. If you suffered a loss on your Honeywell Aerospace Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Honeywell Aerospace Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
Lille (France), Cambridge ( Massachusetts, États-Unis), le 28 septembre 2026 – GENFIT (Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital, a annoncé aujourd’hui ses résultats financiers pour le premier semestre 2026 et fait le point sur ses activités.